Showing 40,261 - 40,280 results of 108,408 for search '(( 5 ((((ng decrease) OR (nn decrease))) OR (a decrease)) ) OR ( a point decrease ))', query time: 1.76s Refine Results
  1. 40261

    Understanding Gas Storage in Cuboctahedral Porous Coordination Cages by Gregory R. Lorzing (4491208)

    Published 2020
    “…As the decrease in crystallinity upon activation of these porous molecular materials precludes diffraction studies, we turn to a related class of pillared coordination cage-based metal–organic frameworks, M<sub>24</sub>(Me-bdc)<sub>24</sub>(dabco)<sub>6</sub> (M = Fe, Co; Me-bdc<sup>2–</sup> = 5-methylisophthalate; dabco = 1,4-diazabicyclo[2.2.2]­octane) for neutron diffraction studies. …”
  2. 40262

    Understanding Gas Storage in Cuboctahedral Porous Coordination Cages by Gregory R. Lorzing (4491208)

    Published 2020
    “…As the decrease in crystallinity upon activation of these porous molecular materials precludes diffraction studies, we turn to a related class of pillared coordination cage-based metal–organic frameworks, M<sub>24</sub>(Me-bdc)<sub>24</sub>(dabco)<sub>6</sub> (M = Fe, Co; Me-bdc<sup>2–</sup> = 5-methylisophthalate; dabco = 1,4-diazabicyclo[2.2.2]­octane) for neutron diffraction studies. …”
  3. 40263

    Understanding Gas Storage in Cuboctahedral Porous Coordination Cages by Gregory R. Lorzing (4491208)

    Published 2020
    “…As the decrease in crystallinity upon activation of these porous molecular materials precludes diffraction studies, we turn to a related class of pillared coordination cage-based metal–organic frameworks, M<sub>24</sub>(Me-bdc)<sub>24</sub>(dabco)<sub>6</sub> (M = Fe, Co; Me-bdc<sup>2–</sup> = 5-methylisophthalate; dabco = 1,4-diazabicyclo[2.2.2]­octane) for neutron diffraction studies. …”
  4. 40264

    Understanding Gas Storage in Cuboctahedral Porous Coordination Cages by Gregory R. Lorzing (4491208)

    Published 2020
    “…As the decrease in crystallinity upon activation of these porous molecular materials precludes diffraction studies, we turn to a related class of pillared coordination cage-based metal–organic frameworks, M<sub>24</sub>(Me-bdc)<sub>24</sub>(dabco)<sub>6</sub> (M = Fe, Co; Me-bdc<sup>2–</sup> = 5-methylisophthalate; dabco = 1,4-diazabicyclo[2.2.2]­octane) for neutron diffraction studies. …”
  5. 40265

    Understanding Gas Storage in Cuboctahedral Porous Coordination Cages by Gregory R. Lorzing (4491208)

    Published 2020
    “…As the decrease in crystallinity upon activation of these porous molecular materials precludes diffraction studies, we turn to a related class of pillared coordination cage-based metal–organic frameworks, M<sub>24</sub>(Me-bdc)<sub>24</sub>(dabco)<sub>6</sub> (M = Fe, Co; Me-bdc<sup>2–</sup> = 5-methylisophthalate; dabco = 1,4-diazabicyclo[2.2.2]­octane) for neutron diffraction studies. …”
  6. 40266

    Understanding Gas Storage in Cuboctahedral Porous Coordination Cages by Gregory R. Lorzing (4491208)

    Published 2020
    “…As the decrease in crystallinity upon activation of these porous molecular materials precludes diffraction studies, we turn to a related class of pillared coordination cage-based metal–organic frameworks, M<sub>24</sub>(Me-bdc)<sub>24</sub>(dabco)<sub>6</sub> (M = Fe, Co; Me-bdc<sup>2–</sup> = 5-methylisophthalate; dabco = 1,4-diazabicyclo[2.2.2]­octane) for neutron diffraction studies. …”
  7. 40267

    Understanding Gas Storage in Cuboctahedral Porous Coordination Cages by Gregory R. Lorzing (4491208)

    Published 2020
    “…As the decrease in crystallinity upon activation of these porous molecular materials precludes diffraction studies, we turn to a related class of pillared coordination cage-based metal–organic frameworks, M<sub>24</sub>(Me-bdc)<sub>24</sub>(dabco)<sub>6</sub> (M = Fe, Co; Me-bdc<sup>2–</sup> = 5-methylisophthalate; dabco = 1,4-diazabicyclo[2.2.2]­octane) for neutron diffraction studies. …”
  8. 40268

    Table_1_Adaptive Homeostatic Strategies of Resilient Intrinsic Self-Regulation in Extremes (RISE): A Randomized Controlled Trial of a Novel Behavioral Treatment for Chronic Pain.do... by Martha Kent (4776228)

    Published 2021
    “…Broadly, results indicated significant intervention and time effects across multiple domains: (1) Pain decreased in present severity [F<sub>(</sub><sub>1, 56)</sub> = 5.02, p < 0.05, η<sup>2</sup><sub>p</sub> = 0.08], total pain over six domains [F<sub>(</sub><sub>1, 56)</sub> = 14.52, p < 0.01, η<sup>2</sup><sub>p</sub> = 0.21], and pain interference [F<sub>(</sub><sub>1, 56)</sub> = 6.82, p < 0.05, η<sup>2</sup><sub>p</sub> = 0.11]; (2) Affect improved in pain-related negative affect [F<sub>(</sub><sub>1, 56)</sub> = 7.44, p < 0.01, η<sup>2</sup><sub>p</sub> = 0.12], fear [F<sub>(</sub><sub>1, 56)</sub> = 7.70, p < 0.01, η<sup>2</sup><sub>p</sub> = 0.12], and distress [F<sub>(</sub><sub>1, 56)</sub> = 10.87, p < 0.01, η<sup>2</sup><sub>p</sub> = 0.16]; (3) Well-being increased in pain mobility [F<sub>(</sub><sub>1, 56)</sub> = 5.45, p < 0.05, η<sup>2</sup><sub>p</sub> = 0.09], vitality [F<sub>(</sub><sub>1, 56)</sub> = 4.54, p < 0.05, η<sup>2</sup><sub>p</sub> = 0.07], and emotional well-being [F<sub>(</sub><sub>1, 56)</sub> = 5.53, p < 0.05, η<sup>2</sup><sub>p</sub> = 0.09] Mental health symptoms and the cognitive functioning domain did not reveal significant effects. …”
  9. 40269

    <i>Foxj1</i> as a target gene for RFX4. by Ping Xu (122619)

    Published 2018
    “…<p>(A) qPCR. <i>Foxj1</i> mRNA levels were decreased in E12.5 KO brains, whereas there were no significant differences in <i>Ift172</i>, <i>Thbs</i>, <i>Dync2li1</i>, <i>Rfx2</i>, <i>Rfx3</i> mRNAs, and almost undetectable <i>Rfx4</i> transcripts compared to the controls (P< 0.0001, n = 5). …”
  10. 40270

    Effect of Ca<sup>2+</sup> flux and adenosine activators and blockers on A<sub>2A</sub>R mRNA and protein levels in PC12 cells. by Zhiyun Wang (360002)

    Published 2013
    “…<p>(<b>A</b>) The A<sub>2A</sub>R agonist CGS21680 increased A<sub>2A</sub>R mRNA levels by over 5-fold while the antagonist ZM241385 as well as SMF decreased this agonist-enhanced A<sub>2A</sub>R transcription to close to control levels (<i>p</i> values for each comparison are shown on the chart for n≥3 independent experiments). …”
  11. 40271
  12. 40272
  13. 40273
  14. 40274

    Modulation masking release reduction as a function of time-compressed speech by Fernando Augusto Pacífico (10444820)

    Published 2021
    “…<div><p>ABSTRACT Purpose: to investigate the magnitude of the modulation masking release in sentence recognition as a function of compression level and modulation rate. …”
  15. 40275

    Production of highly soluble foliar fertilizer in a spouted bed dryer by Ana Carolina Ribeiro Stoppe (15939850)

    Published 2023
    “…In this study, we investigated the drying of foliar fertilizer in a spouted bed using polyethylene pellets as inert particles to improve its solubility. …”
  16. 40276

    Transcriptional collision hypothesis of <i>Ube3a</i> imprinting. by Linyan Meng (502323)

    Published 2013
    “…<p>Paternal <i>Ube3a</i> was found to be transcribed at a similar level as maternal <i>Ube3a</i> at the 5′ portion of the gene. …”
  17. 40277

    Data Sheet 1_Dependence on zopiclone: a case report.docx by Nana Guo (8595126)

    Published 2025
    “…</p>Case presentation<p>This case report describes a 43-year-old male patient who has been taking zopiclone for 12 years, with a maximum daily dose of 112.5 mg. …”
  18. 40278

    Aβ(25-35) aggregation on DOPC/DHA lipid bilayer. by Matilde Sublimi Saponetti (222515)

    Published 2014
    “…<p>(a-c) 5×2.2 µm<sup>2</sup> (1024×431px<sup>2</sup>) topographic AFM images of Aβ(25-35) aggregation on DOPC/DHA lipid bilayers. …”
  19. 40279

    Intrinsic discriminability as a function of input statistics for different model neurons. by Fabiano Baroni (234173)

    Published 2010
    “…E: The same as in A and B, but and have been scaled proportionally in order to maintain a fixed ratio of 0.5. …”
  20. 40280

    Supplementary Material for: Methimazole induced agranulocytosis - A clinical case report by figshare admin karger (2628495)

    Published 2025
    “…On presentation to our clinic, she reported anxiety with no other symptoms and a low dose methimazole (2.5mg/daily) was started. …”